🔗 Permalink

Inventor profile of:

Joseph A. McDONOUGH

City:

Helotes, Texas

Country:

United States

Published Applications:

Last publication date:

2024-11-07

Top Assignees for applications by Joseph A. McDONOUGH

The entities that hold a legal rights for patent applications filed by inventor McDONOUGH Joseph A.:

SOUTHWEST RESEARCH INSTITUTE 21 San Antonio, TX United States
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. 2 Bethesda, MD United States
The Government of the United States As Represented by the Secretary of the Army 2 Fort Detrick, MD United States
SOUTHWEST RESEARCH INSTITUTE 1 San Antoniol, TX United States

Recent patent applications by McDONOUGH Joseph A.

Joseph A. McDONOUGH from Helotes, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-07

US20240366528A1

Human necessities

Compositions Of Dimethyl Trisulfide (DMTS) As A Cyanide Antidote

#2 | 2023-03-09

US20230074535A1

Human necessities

Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD)

#3 | 2023-03-02

US20230065024A1

Human necessities

Inhibitors for coronavirus

#4 | 2020-11-05

US20200345658A1

Human necessities

Compositions of dimethyl trisulfide (DMTS) as a cyanide antidote

#5 | 2019-04-04

US20190099482A1

Human necessities

Liposomal flu vaccine formulation

#6 | 2018-10-25

US20180303823A1

Human necessities

Pharmaceutical salt forms of Cepharanthine and Tetrandrine

#7 | 2018-07-26

US20180207143A1

Human necessities

Aqueous suspensions of oximes for autoinjectors

#8 | 2017-12-28

US20170368042A1

Human necessities

Dosage suspensions of active pharmaceutical ingredients

#9 | 2016-09-29

US20160280716A1

Chemistry; metallurgy

PHARMACEUTICAL SALT FORMS OF CEPHARANTHINE AND TETRANDRINE

#10 | 2015-04-16

US20150105475A1

Chemistry; metallurgy

Point of use generation of amyl nitrite

#11 | 2015-04-16

US20150105474A1

Human necessities

Isoamyl nitrite formulations

#12 | 2013-06-27

US20130164381A1

Human necessities

Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation

#13 | 2012-03-22

US20120070503A1

Human necessities

Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation

#14 | 2011-08-11

US20110195125A1

Human necessities

Nanoparticles for drug delivery to the central nervous system

#15 | 2011-01-20

US20110015568A1

Human necessities

Dry to wet injector

#16 | 2010-04-22

US20100098754A1

Human necessities

Processing of heat-sensitive active agents

#17 | 2010-04-08

US20100086601A1

Human necessities

Modified calcium phosphate nanoparticle formation

#18 | 2010-02-18

US20100040692A1

Human necessities

Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts

#19 | 2009-11-12

US20090281144A1

Chemistry; metallurgy

Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors

#20 | 2008-05-08

US20080107736A1

Human necessities

Pharmaceutically active nanosuspensions

#21 | 2007-03-08

US20070054002A1

Human necessities

Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents

#22 | 2007-03-08

US20070053990A1

Human necessities

Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates

#23 | 2007-03-08

US20070053989A1

Performing operations; transporting

Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents

InventorID:

311669 ⎘